Reported 0 shares, down 315,550 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2020-12-31 | 4399000 |
| 2021-03-31 | 4004000 |
| 2021-06-30 | 2805000 |
| 2021-09-30 | 1761000 |
| 2021-12-31 | 1215000 |
| 2022-03-31 | 417000 |
| 2022-06-30 | 290000 |
| 2022-09-30 | 203000 |
| 2022-12-31 | 224956 |
| 2023-03-31 | 315550 |
| 2023-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | Reduced | 0 | -315,550 (-100.0%) | 0 | $0 | 2023-08-10 | |
| Q1 2023 | Unchanged | 315,550 | 0 (0.0%) | 0.26% | $315,550 | 2023-05-11 | |
| Q4 2022 | Unchanged | 315,550 | 0 (0.0%) | 0.16% | $224,956 | 2023-02-06 | |
| Q3 2022 | Unchanged | 315,550 | 0 (0.0%) | 0.12% | $203,000 | 2022-11-10 | |
| Q2 2022 | Unchanged | 315,550 | 0 (0.0%) | 0.19% | $290,000 | 2022-08-09 | |
| Q1 2022 | Unchanged | 315,550 | 0 (0.0%) | 0.21% | $417,000 | 2022-05-06 | |
| Q4 2021 | Unchanged | 315,550 | 0 (0.0%) | 0.44% | $1,215,000 | 2022-02-11 | |
| Q3 2021 | Unchanged | 315,550 | 0 (0.0%) | 0.51% | $1,761,000 | 2021-11-12 | |
| Q2 2021 | Unchanged | 315,550 | 0 (0.0%) | 0.72% | $2,805,000 | 2021-08-12 | |
| Q1 2021 | Unchanged | 315,550 | 0 (0.0%) | 0.93% | $4,004,000 | 2021-05-12 | |
| Q4 2020 | Unchanged | 315,550 | 0 (0.0%) | 1.02% | $4,399,000 | 2021-02-10 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
55 managers reported AVROBIO INC COM (DE) for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors LLC | Unchanged | 4,541,381 | 0 | 0.54% | $4,314,766 | 7 qtrs |
| TANG CAPITAL MANAGEMENT LLC | Added | 2,705,000 | +2,667,387 | 0.38% | $2,570,021 | 2 qtrs |
| GMT CAPITAL CORP | Reduced | 2,412,015 | -1,945,844 | 0.09% | $2,291,655 | 10 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Unchanged | 1,770,147 | 0 | < 0.01% | $1,680,000 | 8 qtrs |
| VANGUARD GROUP INC | Unchanged | 1,181,134 | 0 | < 0.01% | $1,122,196 | 21 qtrs |
| MORGAN STANLEY | Added | 1,049,270 | +846,425 | < 0.01% | $996,911 | 21 qtrs |
| Aisling Capital Management LP | Unchanged | 1,009,779 | 0 | 0.47% | $959,391 | 19 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 899,700 | -2,216,300 | < 0.01% | $854,805 | 21 qtrs |
| BlackRock Inc | Reduced | 633,036 | -760,333 | < 0.01% | $601,447 | 21 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 562,567 | -10,800 | < 0.01% | $534,000 | 13 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 10, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.